Maven Securities LTD Athira Pharma, Inc. Transaction History

Maven Securities LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$9.15 - $11.09 $514,888 - $624,056	-56,272 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$10.24 - $20.87 $576,225 - $1.17 Million	56,272 New	56,272 $585,000
Q4 2020 Feb 12, 2021	SELL	$16.48 - $34.3 $206,000 - $428,749	-12,500 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$16.02 - $18.46 $200,250 - $230,750	12,500 New	12,500 $207,000

16.9M

112K

68K

Ticker ATHA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,817,700
Market Cap $23.4M
Description
Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. The company's lead product candidate is ATH-1017, a blood brain barrier-penetrating, small molecule HGF/MET positive modulator that is in LIFT-AD Phase 3 and ACT-AD Phase 2 clinical tri...

Get notified when there are updates to the investment portfolio of Maven Securities LTD, based on Form 13F filings with the SEC.

Stay updated on Maven Securities LTD with notifications on news.